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Insulin resistance associated with metabolic syndrome and Type 2 diabetes mellitus is
an  epidemic metabolic disorder, which increases the risk of cardiovascular complications.
Impaired vascular endothelial function is an early marker for atherosclerosis, which causes
cardiovascular complications. Both experimental and clinical studies indicate that endothe-
lial  dysfunction in vasculatures occurs with insulin resistance. The associated physiological
mechanisms are not fully appreciated yet, however, it seems that augmented oxidative
stress, a physiological imbalance between oxidants and antioxidants, in vascular cells is
a  possible mechanism involved in various vascular beds with insulin resistance and hyper-
glycemia. Regardless of the inclusion of resistance exercise, aerobic exercise seems to be
beneﬁcial for vascular endothelial function in both large conduit and small resistance ves-
sels  in both clinical and experimental studies with insulin resistance. In clinical cases,
aerobic exercise over 8 weeks with higher intensity seems more beneﬁcial than the cases
with shorter duration and lower intensity. However, more studies are needed in the future toelucidate the physiological mechanisms by which vascular endothelial function is impaired
in  insulin resistance and improved with aerobic exercise.
© 2016 Korea Institute of Oriental Medicine. Published by Elsevier. This is an open access
article under the CC BY-NC-ND license
hyperglycemia, and dyslipidemia, is closely associated with1.  Introduction
Insulin resistance is a metabolic disorder that reﬂects low
capability to wash glucose out of the bloodstream to tar-
get tissues. Unlike type 1 diabetes mellitus, which results
from disrupted insulin secretion from pancreatic  cells,
type 2 diabetes mellitus is a representative metabolic disease
attributable to increased insulin resistance and decreased
insulin sensitivity.1 Type 2 diabetes mellitus comprises
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> 90% of all cases of diabetes and affected > 350 million
people in 2011.2 In particular, the population of diabetes
mellitus is gradually increasing in Korea, and about 15,000
diabetic patients die every year owing to the associated
complications.2 Metabolic syndrome, a clinically prediabetic
condition characterized by abdominal obesity, hypertension,stitute, Incheon National University, Building Number 16, Room
ea.
increased insulin resistance in etiology. Approximately 25% of
the adult population is considered to be at risk of metabolic
syndrome globally,3 and about 35% of the adult population in
vier. This is an open access article under the CC BY-NC-ND license
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he United States is reported to have metabolic syndrome.4
n Korea, the population with metabolic syndrome increased
rom 25% in 1998 to 31% in 2007.5 Metabolic syndrome and
ype 2 diabetes mellitus are etiologically similar because they
hare two common causes: insulin resistance and abdominal
besity.6 Thus, patients with metabolic syndrome have about
ve times higher possibility to progress into type 2 diabetes
ellitus compared with those without metabolic syndrome.7
Patients with type 2 diabetes mellitus or metabolic
yndrome are usually at elevated risk of cardiovascular
isease.2,8,9 Degenerative alterations in vascular structure and
unction in the metabolic diseases result in atherosclero-
is, a main cause of cardiovascular disease.8 Atherosclerosis
esults from dysfunction of the vascular endothelium, which
s closely related to decreased NO bioavailability and increased
ndothelium-derived contraction factors in blood vessels.10
revious studies have indicated that excessive oxidative stress
n the vasculature of patients with with metabolic disease is
 possible mechanism to cause reduction in NO bioavailabil-
ty and to impair vascular endothelial function.9,11–13 However,
ew studies have demonstrated the physiological mechanisms
rom vascular cells in patients with metabolic disease. Regular
hysical activity is known as a strategy to reverse vascu-
ar dysfunction and to prevent future cardiovascular disease.
owever, a few studies have investigated the effect of exercise
raining on vascular function in patients with type 2 diabetes
ellitus and metabolic syndrome.14–17 Thus, the purpose of
his review is to introduce potential physiological mechanisms
y which vascular function is impaired in augmented insulin
esistance, to summarize previous studies to investigate the
ffects of exercise training on vascular function in type 2
iabetes mellitus and metabolic syndrome, and to facilitate
elated studies in the future.
.  Insulin  resistance  and  oxidative  stress:  a
utative  physiological  mechanism  to  cause
ascular  dysfunction
ncreased insulin resistance leads to augmented glucose level
n the bloodstream. Since vascular endothelium is the single
nnermost layer in the vascular structure, vascular endothe-
ial cells are likely to be damaged by hyperglycemic stress,
uggesting that metabolic dysfunction such as insulin resis-
ance and type 2 diabetic mellitus may result in vascular
ysfunction.18 It has been demonstrated that the genera-
ion of reactive oxygen species (ROS) is increased in both
arge and small vascular beds collected from hyperglycemic
nimal models.19 In a hyperglycemic environment, elevated
OS generation in vascular cells can be inﬂuenced by various
iological signaling pathways. Aldose reductase, in hyper-
lycemic conditions, converts glucose to sorbitol by using
icotinamide adenine dinucleotide phosphate as a cofactor,
hus the regeneration of reduced glutathione is reduced and
ntracellular oxidative stress level is increased.2,20,21 Increased
dvanced glycation end-products lead to increased recep-
or activity, which facilitates ROS and inﬂammatory cytokine
roduction.2,22,23 Activation of the diacylglycerol–protein
inase C pathway also contributes to the elevated gen-
ration of ROS and inﬂammatory cytokines.2,24–26 In the199
overloaded glycolytic pathway induced by hyperglycemia,
uridine diphosphate N-acetyl glucosamine has a negative
effect on endothelial NO synthase activity by obstructing its
phosphorylation at serine 1177 and increases the expression
of proinﬂammatory cytokines such as transforming growth
factor-1 and plasminogen activator inhibitor-1.2,27–29 In the
vascular endothelium, oxidative stress induced by increased
ROS generation not only directly plays a pivotal role in reduc-
ing NO bioavailability, but also leads to increased expression
of proinﬂammatory cytokines so that proatherogenic and pro-
thrombotic processes are abnormally facilitated.30 Thus, the
structural and functional integrity of vascular endothelium is
likely to be damaged with insulin resistance, which increases
the risk of cardiovascular disease in those who  are continu-
ously exposed to hyperglycemia in the circulation.
3.  Insulin  resistance  and  exercise:  effects
on  vascular  function
Insulin signaling in local vascular cells is essential to promote
vascular endothelial NO production.31 Thus, the increase in
insulin resistance in the vasculature has a negative effect
on vascular endothelial function and cardiovascular morbid-
ity and mortality. Regular physical activity and exercise are
known to promote cardiovascular health in those with insulin
resistance.
3.1.  Effect  of  exercise  training  on  vascular  function  in
individuals  with  insulin  resistance
There are no speciﬁc exercise guidelines for metabolic syn-
drome patients to preserve and promote their cardiovascular
health. Even though their joint statements were published in
both 2000 and 2010, the American College of Sport Medicine
and the American Diabetes Association only provide generic
exercise regimens for diabetic patients.32,33 In the two  pre-
vious position standards, the experts recommended aerobic
exercise or aerobic exercise combined with resistance exer-
cise to prevent and promote cardiovascular disease risk in
patients with diabetes. However, the effect of either aer-
obic or combined exercise training on both micro- and
macrovascular endothelial function is still in debate. Some
studies presented positive results of exercise training,17,34–36
but others did not show any positive effect of exercise on
vascular health in type 2 diabetic patients.37–39 For individ-
uals with metabolic syndrome, a small number of studies
have explored the effect of exercise training on vascular
endothelial function, but the training effect has presented
a positive tendency,14,15,40,41 and had a close relationship
with increased NO bioavailability.42 It is established that
insulin resistance contributes to impaired vascular endothe-
lial function,31 and either aerobic or combined exercise
training programs might help to reverse endothelial dys-
function in those who have insulin resistance.14,15,17,34–36,40,41
Exercise intensity also seems to be a main factor inﬂu-
encing exercise effects in people with insulin resistance.
Although both moderate-intensity continuous training and
high-intensity interval training have shown improvement
in vascular endothelial function, in the same caloric
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Table 1 – Effect of exercise training on vascular endothelial function in individuals with IR
Disease
(n)
Age (y) Sex Ex
mode
Ex
intensity
Ex
frequency
Ex  time
/duration
Vessel
studied
Conclusion Refs
IR (9)
T2DM (14)
37
43
Both Aerobic Moderate 3–4 d/wk 20–40 min
/8 wk
Conduit ACh-induced
vasorelaxation↑
34
T2DM (16) – – Aerobic and
resistance
Moderate 3 d/wk 1 h
/8 wk
Conduit
resistance
Flow-mediated
vasodilation↑
ACh-induced
vasorelaxation↑
35
T2DM (38) 62 Both Aerobicand
resistance
Moderate 3–5 d/wk 75 min
/12 wk
Conduit Flow-mediated
vasodilation↑
17
T2DM (43) 62 Both Aerobic Moderate 3 d/wk 30–40 min
/3 mo
Conduit Flow-mediated
vasodilation↑
36
T2DM (42) 67 Both Aerobicand
resistance
Moderate 3–5 d/wk 20–30 min
/4 wk
Conduit Flow-mediated
vasodilation =
37
T2DM (59) 63 Both Aerobic Moderate 3 d/wk 30 min
/6  mo
Micro (skin) ACh-induced
vasorelaxation
=
38
T2DM (18) 60 Male Aerobic and
resistance
Moderate 3 d/wk 1 h
/8 wk
Conduit Flow-mediated
vasodilation =
39
MS (29) 40–60 Male Aerobic Moderate 3 d/wk 50 min
/12 wk
Conduit Flow-mediated
vasodilation↑
40
MS (28) — Both Aerobic Moderate
High
3  d/wk 40–47min
/16 wk
Conduit Flow-mediated
vasodilation↑
Flow-mediated
vasodilation↑↑
14
MS (32) 50–55 Both Aerobic Moderate
High
3  d/wk 40–47 min
/16 wk
Conduit Flow-mediated
vasodilation↑
Flow-mediated
vasodilation↑
15
MS (38) 50–70 Both Aerobicand
resistance
Not
addressed
4–5  d/wk 90 min
/6  mo
Micro (skin) ACh-induced
vasorelaxation↑
41
 syndACh, acetylcholine; Ex, exercise; IR, insulin resistance; MS, metabolic
=, no change.
expenditure, high-intensity interval training presents supe-
rior effect on vascular endothelial function and glycemic
control.15,36 The physiological mechanisms by which either
aerobic or combined exercise training enhances vascular
endothelial function in insulin resistance are not fully
elucidated. Positive changes in oxidative stress and inﬂam-
matory biomarkers after exercise training are thought to be
potential mechanisms from animal and systemic biomarker
studies,8,43–45 but no study has investigated the local alter-
ations of potential biomarkers in human vasculature in
response to acute or chronic exercise training in insulin
resistance. Furthermore, it is also necessary to ﬁgure out
a mechanistic linkage between exercise intensity and func-
tional alteration of vascular endothelium. Table 1 shows a
summary of studies examining the effect of exercise on
endothelial function in individuals with insulin resistance.
3.2.  Effect  of  exercise  on  vascular  dysfunction  in
experimental  animal  models
Current evidence indicates that metabolic disease such as
insulin resistance or metabolic syndrome induced vascu-
lar dysfunction in various animal models (Table 2). Even
though a majority of previous studies have indicated that
insulin resistance or metabolic syndrome induced vascular
dysfunction, some studies also showed that these predia-
betic conditions did not change endothelial function. Theserome; T2DM, Type 2 diabetes mellitus; ↑, increase; ↑↑,  more increase;
discrepant conclusions suggest that alteration of vascular
function is affected by multiple factors including duration
of certain diseases and vascular beds. For example, a num-
ber of studies showed that obesity (high-fat diet) induced
insulin resistance caused acetylcholine-induced endothelial
dysfunction in various blood vessels, including coronary arte-
rioles, gracilis artery, femoral artery and aorta in mouse
models,46–49 whereas some studies indicated that insulin
resistance did not induce vascular dysfunction in femoral
artery, mesentery arterioles and aorta.48,50,51 In addition,
some studies showed that type of agonists induced incon-
sistent results in the same vascular beds.50,52,53 For instance,
insulin resistance caused impaired insulin-dependent vasore-
laxation, however, acetylcholine-induced vasorelaxation was
identical in mesenteric arterioles of C57Bl/6J mice.50,52
By contrast, in the femoral artery of C57BL/6J mice,
insulin resistance did not change insulin-induced vasorelax-
ation, but acetylcholine-induced vasorelaxation was reduced
by insulin resistance.53 Table 2 summarizes the effect
of insulin resistance or metabolic syndrome on vasore-
laxation in various vasculatures in experimental animal
models.
It is well documented that exercise or regular physical
activity has beneﬁcial effects on metabolic diseases in animal
models. Considering previous studies, most exercise proto-
cols improved vascular function in various vascular beds such
as coronary arterioles, arterioles, feed arteries from skeletal
M.-H. Hwang and S. Lee/Insulin Resistance 201
Table 2 – Effect of insulin resistance or metabolic syndrome on vasorelaxation in various vasculatures in experimental
animal models
Animals Sex Disease Vessel studied Conclusion Refs
C57BL/6 mice Female IR Coronary arteriole ACh–induced vasorelaxation ↓
Flow-mediated vasorelaxation ↓
46
C57BL/6J mice Female IR Aorta ACh-induced vasorelaxation ↓
Insulin-induced vasorelaxation ↓
48
Femoral artery ACh-induced vasorelaxation =
C57BL/6J mice Male IR Aorta ACh–induced vasorelaxation = 51
C57BL/6J mice Male IR Aorta ACh-induced vasorelaxation ↓ 54
C57BL/6J mice Male IR Femoral artery ACh-induced vasorelaxation ↓
Insulin-induced vasorelaxation =
53
C57BL/6J mice Male IR Coronary artery ACh-induced vasorelaxation =
Insulin-induced vasorelaxation =
49
Aorta ACh-induced vasorelaxation ↓
C57BL/6J mice Male IR Aorta ACh-induced vasorelaxation = 55
C57BL/6J mice Male MS Superior mesenteric
artery
ACh-induced vasorelaxation ↓ 56
C57BL/6J mice Male IR Mesentery arteriole ACh-induced vasorelaxation =
Insulin-induced vasorelaxation ↓
50
C57BL/6J mice Male IR Gracilis artery ACh-induced vasorelaxation ↓ 47
C57BL/6J mice Not speciﬁed Obesity Femoral artery ACh-induced vasorelaxation ↓ 57
C57BL/6J mice Not speciﬁed IR Mesentery arteriole Insulin-induced vasorelaxation ↓
ACh–induced vasorelaxation =
52
B6D2F1 mice Male IR by aging Artery from
epididymal white
adipose tissue
ACh-induced vasorelaxation ↓ 58
New Zealand
Obese Mice
Male MS Mesenteric artery ACh-induced vasorelaxation ↓
Bradykinin-induced
vasorelaxation ↓
59
Ossabaw
swine
Male MS LAD Coronary blood ﬂow ↓ 60
ACh, acetylcholine; IR, insulin resistance; LAD, left anterior descending; MS, metabolic syndrome; ↓, decrease; =, no change.
Table 3 – Effect of exercise on vascular dysfunction induced by IR or MS in experimental animal models
Animals Sex Disease Vessel studied Type of EX Ex effect Refs
C57BL/6 mice Female IR Coronary arteriole Voluntary wheel running ACh-induced
vasorelaxation ↑
Flow-mediated
vasorelaxation ↑
46
C57BL/6 mice Male IR Aorta Treadmill exercise ACh-induced
vasorelaxation ↑
49
OLETF rats Male IR Arteriole from
white skeletal
muscle
Voluntary wheel running Insulin-induced
vasorelaxation ↑
61
OLETF rats Male IR Gastrocnemius feed
artery
Voluntary wheel running ACh-induced
vasorelaxation ↑
62
Soleus feed artery ACh-induced
vasorelaxation =
Low intrinsic aerobic
treadmill running
capacity rats
Male Metabolic
syndrome
Aorta Continuous
moderate-intensity
exercise,
high-intensity aerobic
interval training
ACh-induced
vasorelaxation ↑
63
 synd
m
m
c
d
dACh, acetylcholine; Ex, exercise; IR, insulin resistance; MS, metabolic
change.
uscle and aorta (Table 3). However, it is still unclear which
echanisms are involved in these beneﬁcial effects of exer-ise. Table 3 summarizes the effect of exercise on vascular
ysfunction induced by insulin resistance or metabolic syn-
rome in experimental animal models.rome; OLETF, Otsuka Long–Evans Tokushima Fatty; ↑, increase; =, no
4.  ConclusionThere is no doubt that physical activity or regular exercise
has beneﬁcial effects on vascular function. However, it should
r202  
be noted that some discrepancies exist among these studies
according to experimental design including type of exercise,
intensity and duration of exercise, and heterogeneity of vas-
cular beds. It seems that vascular function in smaller resistant
arteries may be altered differently compared to larger ves-
sels such as aorta and conduit arteries, based on the status of
disease, exercise type, duration, and intensity. Further inves-
tigations are needed to explain mechanisms involved in these
signaling pathways.
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